Muscarinic receptor M4 positive allosteric modulators attenuate central effects of cocaine

Camilla Dall; Pia Weikop; Ditte Dencker; Anna C Molander; Gitta Wörtwein; P Jeffrey Conn; Anders Fink-Jensen; Morgane Thomsen

doi:10.1016/j.drugalcdep.2017.03.014

Muscarinic receptor M₄positive allosteric modulators attenuate central effects of cocaine

Camilla Dall, Pia Weikop, Ditte Dencker, Anna C Molander, Gitta Wörtwein, P Jeffrey Conn, Anders Fink-Jensen, Morgane Thomsen

Department of Clinical Medicine

9 Citations (Scopus)

Abstract

BACKGROUND: Cocaine addiction is a chronic brain disease affecting neurotransmission. Muscarinic cholinergic receptors modulate dopaminergic signaling in the reward system, and muscarinic receptor stimulation can block direct reinforcing effects of cocaine. Here, we tested the hypothesis that specific muscarinic M4receptor stimulation can attenuate the discriminative stimulus effects and conditioned rewarding effects of cocaine, measures believed to predict the ability of cocaine and cocaine-associated cues to elicit relapse to drug taking.

METHODS: We tested the M4-selective positive allosteric modulators VU0152100 and VU0467154 in a drug discrimination assay and a conditioned place preference assay, including extinction and reinstatement of place preference. Specificity of the cocaine discrimination effect was verified using knockout mice lacking either M1or M4receptors (M1-/-, M4-/-). We also replicated previous findings in cocaine-induced locomotor hyperactivity and striatal dopamine microdialysis assays.

RESULTS: VU0152100 attenuated the discriminative stimulus effect of cocaine in wild-type mice and M1-/-mice, but not in M4-/-mice, without affecting rates of responding. As previously shown with VU0152100, VU0467154 almost eliminated cocaine-induced hyperactivity and striatal dopamine efflux. VU0467154 failed to attenuate acquisition of cocaine-conditioned place preference, but facilitated extinction and prevented reinstatement of the conditioned place preference.

CONCLUSIONS: These findings further support the notion that M4receptors are promising targets for the treatment of cocaine addiction, by showing that results can be replicated using distinct ligands, and that in addition to blocking reinforcing effects of cocaine relevant to ongoing drug taking, M4positive allosteric modulators can also attenuate subjective and conditioned effects relevant to relapse.

Original language	English
Journal	Drug and Alcohol Dependence
Volume	176
Pages (from-to)	154-161
ISSN	0376-8716
DOIs	https://doi.org/10.1016/j.drugalcdep.2017.03.014
Publication status	Published - 1 Jul 2017

Keywords

Animals
Cocaine
Cocaine-Related Disorders/drug therapy
Corpus Striatum/drug effects
Hyperkinesis/chemically induced
Male
Mice
Mice, Knockout
Pyridazines/pharmacology
Pyridines/pharmacology
Reinforcement (Psychology)
Reward
Thiophenes/pharmacology

Access to Document

10.1016/j.drugalcdep.2017.03.014

Cite this

@article{159503c3bbb54808bd932153748e69ae,

title = "Muscarinic receptor M4 positive allosteric modulators attenuate central effects of cocaine",

abstract = "BACKGROUND: Cocaine addiction is a chronic brain disease affecting neurotransmission. Muscarinic cholinergic receptors modulate dopaminergic signaling in the reward system, and muscarinic receptor stimulation can block direct reinforcing effects of cocaine. Here, we tested the hypothesis that specific muscarinic M4receptor stimulation can attenuate the discriminative stimulus effects and conditioned rewarding effects of cocaine, measures believed to predict the ability of cocaine and cocaine-associated cues to elicit relapse to drug taking.METHODS: We tested the M4-selective positive allosteric modulators VU0152100 and VU0467154 in a drug discrimination assay and a conditioned place preference assay, including extinction and reinstatement of place preference. Specificity of the cocaine discrimination effect was verified using knockout mice lacking either M1or M4receptors (M1-/-, M4-/-). We also replicated previous findings in cocaine-induced locomotor hyperactivity and striatal dopamine microdialysis assays.RESULTS: VU0152100 attenuated the discriminative stimulus effect of cocaine in wild-type mice and M1-/-mice, but not in M4-/-mice, without affecting rates of responding. As previously shown with VU0152100, VU0467154 almost eliminated cocaine-induced hyperactivity and striatal dopamine efflux. VU0467154 failed to attenuate acquisition of cocaine-conditioned place preference, but facilitated extinction and prevented reinstatement of the conditioned place preference.CONCLUSIONS: These findings further support the notion that M4receptors are promising targets for the treatment of cocaine addiction, by showing that results can be replicated using distinct ligands, and that in addition to blocking reinforcing effects of cocaine relevant to ongoing drug taking, M4positive allosteric modulators can also attenuate subjective and conditioned effects relevant to relapse.",

keywords = "Animals, Cocaine, Cocaine-Related Disorders/drug therapy, Corpus Striatum/drug effects, Hyperkinesis/chemically induced, Male, Mice, Mice, Knockout, Pyridazines/pharmacology, Pyridines/pharmacology, Reinforcement (Psychology), Reward, Thiophenes/pharmacology",

author = "Camilla Dall and Pia Weikop and Ditte Dencker and Molander, {Anna C} and Gitta W{\"o}rtwein and Conn, {P Jeffrey} and Anders Fink-Jensen and Morgane Thomsen",

note = "Copyright {\textcopyright} 2017. Published by Elsevier B.V.",

year = "2017",

month = jul,

day = "1",

doi = "10.1016/j.drugalcdep.2017.03.014",

language = "English",

volume = "176",

pages = "154--161",

journal = "Drug and Alcohol Dependence",

issn = "0376-8716",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Muscarinic receptor M4 positive allosteric modulators attenuate central effects of cocaine

AU - Dall, Camilla

AU - Weikop, Pia

AU - Dencker, Ditte

AU - Molander, Anna C

AU - Wörtwein, Gitta

AU - Conn, P Jeffrey

AU - Fink-Jensen, Anders

AU - Thomsen, Morgane

PY - 2017/7/1

Y1 - 2017/7/1

N2 - BACKGROUND: Cocaine addiction is a chronic brain disease affecting neurotransmission. Muscarinic cholinergic receptors modulate dopaminergic signaling in the reward system, and muscarinic receptor stimulation can block direct reinforcing effects of cocaine. Here, we tested the hypothesis that specific muscarinic M4receptor stimulation can attenuate the discriminative stimulus effects and conditioned rewarding effects of cocaine, measures believed to predict the ability of cocaine and cocaine-associated cues to elicit relapse to drug taking.METHODS: We tested the M4-selective positive allosteric modulators VU0152100 and VU0467154 in a drug discrimination assay and a conditioned place preference assay, including extinction and reinstatement of place preference. Specificity of the cocaine discrimination effect was verified using knockout mice lacking either M1or M4receptors (M1-/-, M4-/-). We also replicated previous findings in cocaine-induced locomotor hyperactivity and striatal dopamine microdialysis assays.RESULTS: VU0152100 attenuated the discriminative stimulus effect of cocaine in wild-type mice and M1-/-mice, but not in M4-/-mice, without affecting rates of responding. As previously shown with VU0152100, VU0467154 almost eliminated cocaine-induced hyperactivity and striatal dopamine efflux. VU0467154 failed to attenuate acquisition of cocaine-conditioned place preference, but facilitated extinction and prevented reinstatement of the conditioned place preference.CONCLUSIONS: These findings further support the notion that M4receptors are promising targets for the treatment of cocaine addiction, by showing that results can be replicated using distinct ligands, and that in addition to blocking reinforcing effects of cocaine relevant to ongoing drug taking, M4positive allosteric modulators can also attenuate subjective and conditioned effects relevant to relapse.

AB - BACKGROUND: Cocaine addiction is a chronic brain disease affecting neurotransmission. Muscarinic cholinergic receptors modulate dopaminergic signaling in the reward system, and muscarinic receptor stimulation can block direct reinforcing effects of cocaine. Here, we tested the hypothesis that specific muscarinic M4receptor stimulation can attenuate the discriminative stimulus effects and conditioned rewarding effects of cocaine, measures believed to predict the ability of cocaine and cocaine-associated cues to elicit relapse to drug taking.METHODS: We tested the M4-selective positive allosteric modulators VU0152100 and VU0467154 in a drug discrimination assay and a conditioned place preference assay, including extinction and reinstatement of place preference. Specificity of the cocaine discrimination effect was verified using knockout mice lacking either M1or M4receptors (M1-/-, M4-/-). We also replicated previous findings in cocaine-induced locomotor hyperactivity and striatal dopamine microdialysis assays.RESULTS: VU0152100 attenuated the discriminative stimulus effect of cocaine in wild-type mice and M1-/-mice, but not in M4-/-mice, without affecting rates of responding. As previously shown with VU0152100, VU0467154 almost eliminated cocaine-induced hyperactivity and striatal dopamine efflux. VU0467154 failed to attenuate acquisition of cocaine-conditioned place preference, but facilitated extinction and prevented reinstatement of the conditioned place preference.CONCLUSIONS: These findings further support the notion that M4receptors are promising targets for the treatment of cocaine addiction, by showing that results can be replicated using distinct ligands, and that in addition to blocking reinforcing effects of cocaine relevant to ongoing drug taking, M4positive allosteric modulators can also attenuate subjective and conditioned effects relevant to relapse.

KW - Animals

KW - Cocaine

KW - Cocaine-Related Disorders/drug therapy

KW - Corpus Striatum/drug effects

KW - Hyperkinesis/chemically induced

KW - Male

KW - Mice

KW - Mice, Knockout

KW - Pyridazines/pharmacology

KW - Pyridines/pharmacology

KW - Reinforcement (Psychology)

KW - Reward

KW - Thiophenes/pharmacology

U2 - 10.1016/j.drugalcdep.2017.03.014

DO - 10.1016/j.drugalcdep.2017.03.014

M3 - Journal article

C2 - 28544993

SN - 0376-8716

VL - 176

SP - 154

EP - 161

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence